Incyte Capital Surpluse from 2010 to 2024

INCY Stock  USD 53.76  0.67  1.26%   
Incyte Capital Surpluse yearly trend continues to be fairly stable with very little volatility. Capital Surpluse will likely drop to about 3.4 B in 2024. During the period from 2010 to 2024, Incyte Capital Surpluse regression line of annual values had r-squared of  0.80 and arithmetic mean of  3,051,921,550. View All Fundamentals
 
Capital Surpluse  
First Reported
2011-03-31
Previous Quarter
4.9 B
Current Value
4.9 B
Quarterly Volatility
1.3 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Incyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Incyte main balance sheet or income statement drivers, such as Depreciation And Amortization of 86.8 M, Interest Expense of 2.4 M or Total Revenue of 3.9 B, as well as many exotic indicators such as Price To Sales Ratio of 3.61, Dividend Yield of 0.0 or PTB Ratio of 2.84. Incyte financial statements analysis is a perfect complement when working with Incyte Valuation or Volatility modules.
  
This module can also supplement Incyte's financial leverage analysis and stock options assessment as well as various Incyte Technical models . Check out the analysis of Incyte Correlation against competitors.
For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.

Latest Incyte's Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of Incyte over the last few years. It is Incyte's Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Incyte's overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

Incyte Capital Surpluse Regression Statistics

Arithmetic Mean3,051,921,550
Geometric Mean2,720,684,364
Coefficient Of Variation47.08
Mean Deviation1,289,810,380
Median3,380,486,100
Standard Deviation1,436,843,941
Sample Variance2064520.5T
Range4.1B
R-Value0.90
Mean Square Error435400.5T
R-Squared0.80
Slope288,116,302
Total Sum of Squares28903287.1T

Incyte Capital Surpluse History

20243.4 B
20235.5 B
20224.8 B
20214.6 B
20204.4 B
2019B
20183.8 B

About Incyte Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Incyte income statement, its balance sheet, and the statement of cash flows. Incyte investors use historical funamental indicators, such as Incyte's Capital Surpluse, to determine how well the company is positioned to perform in the future. Although Incyte investors may use each financial statement separately, they are all related. The changes in Incyte's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Incyte's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Incyte Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Incyte. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Surpluse5.5 B3.4 B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Incyte offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Incyte's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Incyte Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Incyte Stock:
Check out the analysis of Incyte Correlation against competitors.
For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.
Note that the Incyte information on this page should be used as a complementary analysis to other Incyte's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Incyte Stock analysis

When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stocks Directory
Find actively traded stocks across global markets
Is Incyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
6.705
Earnings Share
3.3
Revenue Per Share
16.82
Quarterly Revenue Growth
0.089
Return On Assets
0.0689
The market value of Incyte is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte's value that differs from its market value or its book value, called intrinsic value, which is Incyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte's market value can be influenced by many factors that don't directly affect Incyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.